Literature DB >> 17098298

Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats.

Eric Murillo-Rodríguez1, Reyes Haro, Marcela Palomero-Rivero, Diana Millán-Aldaco, René Drucker-Colín.   

Abstract

Modafinil (MOD) is a wakefulness-promoting drug that improves the alertness levels in narcolepsy; however, the molecular mechanism of action remains to be elucidated. We found that after a single icv injection of MOD (10 microg/5 microl) the extracellular levels of dopamine (DA) and l-DOPA collected from the nucleus accumbens were increased and decreased, respectively. Separately, the icv administration of MOD (10 microg/5 microl) to rats enhanced wakefulness (W) whereas diminished sleep during 4h. Lastly, the alertness induced by MOD was partially antagonized by the sleep-inducing endocannabinoid anandamide (ANA). We conclude that MOD enhances the extracellular levels of DA, promotes W and its effects on sleep are partially blocked by ANA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17098298     DOI: 10.1016/j.bbr.2006.10.016

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  26 in total

1.  Effect of psychostimulants on impulsivity and risk taking in narcolepsy with cataplexy.

Authors:  Sophie Bayard; Muriel Croisier Langenier; Yves Dauvilliers
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

2.  Essential role of dopamine D2 receptor in the maintenance of wakefulness, but not in homeostatic regulation of sleep, in mice.

Authors:  Wei-Min Qu; Xin-Hong Xu; Ming-Ming Yan; Yi-Qun Wang; Yoshihiro Urade; Zhi-Li Huang
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

3.  Receptor-Based Discovery of a Plasmalemmal Monoamine Transporter Inhibitor via High Throughput Docking and Pharmacophore Modeling.

Authors:  Martín Indarte; Yi Liu; Jeffry D Madura; Christopher K Surratt
Journal:  ACS Chem Neurosci       Date:  2010-03-17       Impact factor: 4.418

Review 4.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

5.  The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans.

Authors:  Dawn E Sugarman; James Poling; Mehmet Sofuoglu
Journal:  Pharmacol Biochem Behav       Date:  2010-12-21       Impact factor: 3.533

6.  Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat.

Authors:  Alessandro Gozzi; Valeria Colavito; Paul F Seke Etet; Dino Montanari; Silvia Fiorini; Stefano Tambalo; Angelo Bifone; Gigliola Grassi Zucconi; Marina Bentivoglio
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

7.  Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.

Authors:  Nora D Volkow; Joanna S Fowler; Jean Logan; David Alexoff; Wei Zhu; Frank Telang; Gene-Jack Wang; Millard Jayne; Jacob M Hooker; Christopher Wong; Barbara Hubbard; Pauline Carter; Donald Warner; Payton King; Colleen Shea; Youwen Xu; Lisa Muench; Karen Apelskog-Torres
Journal:  JAMA       Date:  2009-03-18       Impact factor: 56.272

Review 8.  Adjunctive use of modafinil in bipolar patients: just another stimulant or not?

Authors:  Richard C Shelton; Rakesh Reddy
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

9.  Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: implications for addiction.

Authors:  Tristan Shuman; Denise J Cai; Jennifer R Sage; Stephan G Anagnostaras
Journal:  Behav Brain Res       Date:  2012-08-03       Impact factor: 3.332

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.